- The Wall Street Journal reported that Baxter International Inc (NYSE:BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE:HRC) for about $10 billion, citing people familiar with the matter.
- The report said a takeover deal could value Hill-Rom at around $150 per share, and the agreement could be reached by midweek if the talks do not fall apart.
- The talks follow an earlier bid from Baxter worth $144/share that Hill-Rom rebuffed.
- Related Content: Baxter In Early Talks To Acquire Hill Rom
- Hill-Rom currently has nearly $9 billion market capitalization, while Baxter’s is around $37 billion.
- Price Action: BAX stock is trading 0.99% higher at $74.70, and HRC stock is up 8.35% at $144 in the premarket session on the last check Monday.
Jefferies Downgrades Nektar Therapeutics to Underperform, Lowers Price Target to $1.5
Jefferies analyst Roger Song downgrades Nektar Therapeutics (NASDAQ:NKTR) from Hold to Underperform and lowers the price target from $3.2 to $1.5.
